Taurus Meds TRT Claims Evaluated: Powerful Testosterone Replacement Therapy & Taurus Charge ED Medication

3 weeks ago

Wilmington, DE, May 28, 2026 (GLOBE NEWSWIRE) -- Compounded medications are not FDA-approved finished drug products and are not subject…

Cendyn resets hospitality commitment with leadership reorientation

3 weeks ago

CEO Michael Bennett leads a restructured team built on operator experience, with a clear focus on helping hotels compete in…

Antaisolar Launches We Cover Solar Roof One-Stop Solution

3 weeks ago

XIAMEN, China, May 26, 2026 /PRNewswire/ -- On May 20, Antaisolar has launched its We Cover | Solar Roof One-stop Solution,…

XPPen Debuts Its First-Ever Editing Console, the Pilot Pro, Setting a New Benchmark for Professional Editing Workflows

3 weeks ago

LOS ANGELES, May 18, 2026 /PRNewswire/ -- As a leading global digital art brand, XPPen has long been committed to empowering…

Haier Named the World’s Only IoT Ecosystem Brand in Kantar BrandZ Top 100 for Eight Consecutive Years

3 weeks ago

QINGDAO, China, May 18, 2026 /PRNewswire/ -- Kantar, a global leader in brand data and strategy consulting, recently released its…

Xinhua Silk Road: Profound world cultural heritage empowers Quanzhou’s transformation into “fashion capital”

3 weeks ago

BEIJING, May 11, 2026 /PRNewswire/ -- Quanzhou, a historical city in southeast China's Fujian Province, has been promoting its transformation…

Menarini Group Presents New Data from the Phase 1b/2 ELEVATE Study of Elacestrant in Combination with Capivasertib in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting

3 weeks ago

Encouraging safety and preliminary efficacy analysis from the elacestrant and capivasertib Phase 1b regimen of the ELEVATE study will be presented.The…

Haier Biomedical Achieves Double No. 1 Ranking in Euromonitor’s Global Life Science Lab Equipment Report, Caps Three-Phase Global Expansion

3 weeks ago

QINGDAO, China, May 28, 2026 /PRNewswire/ -- Haier Biomedical (SHA: 688139) has been named the No. 1 Chinese brand in…

EquiLend Names Delta Capita as an Implementation Partner for EquiLend Spire

3 weeks ago

Strategic partnership to deliver a structured, scalable onboarding and experience for Spire clientsNEW YORK, May 28, 2026 /PRNewswire/ -- EquiLend,…

NYSE Content Update: Hinge Health Shares Up 72% One Year from its IPO

3 weeks ago

NYSE issues a pre-market daily advisory direct from the trading floor.NEW YORK, May 28, 2026 /PRNewswire/ -- The New York…